证券代码：688199 证券简称：久日新材 公告编号：2025-047 天津久日新材料股份有限公司 董事、高级管理人员提前终止减持计划暨 减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 董事、高级管理人员持股的基本情况 本次减持计划实施前，天津久日新材料股份有限公司（以下简称公司）董事寇 福平先生持有公司股份 149,000 股，占公司总股本的 0.0924%；公司财务总监马秀 玲女士持有公司股份 246,786 股，占公司总股本的 0.1531%。前述股份来源为公司 首次公开发行股票并上市前取得的股份及公司实施 2023 年年度利润分配暨资本公 积金转增股本方案取得的股份，均为无限售流通股。 减持计划的实施结果情况 2025 年 6 月 30 日，公司披露了《天津久日新材料股份有限公司董事、高级管 理人员减持股份计划公告》（公告编号：2025-035），寇福平先生计划以集中竞价交 易方式减持公司股份不超过 37,250 股，即减持不超过公司总股本的 0.0231%，不 超过其可 ...

Core Viewpoint - As of August 25, 2025, Jiuri New Materials (688199) reported a closing price of 29.19 yuan, reflecting a 1.11% increase, with a trading volume of 116,800 hands and a transaction amount of 336 million yuan [1] Financial Performance - For the first half of 2025, the company reported total operating revenue of 713 million yuan, a year-on-year decrease of 7.11% [1] - The net profit attributable to shareholders was 9.06 million yuan, showing a year-on-year increase of 29.69% [1] - The non-recurring net profit was 10.17 million yuan, up 44.86% year-on-year [1] - The current ratio was 1.454, the quick ratio was 1.154, and the debt-to-asset ratio stood at 35.99% [1] Capital Flow - On the reporting day, the main capital saw a net outflow of 29.30 million yuan, accounting for 8.73% of the transaction amount [1] - Large orders experienced a net outflow of 21.13 million yuan, representing 6.29% of the transaction amount, while small orders had a net inflow of 32.16 million yuan, making up 9.58% of the transaction amount [1] Company Background - Tianjin Jiuri New Materials Co., Ltd. was established in 1998 and is primarily engaged in the manufacturing of chemical raw materials and products [2] - The company has a registered capital of 1.612 billion yuan and a paid-in capital of 50 million yuan [1][2] - The legal representative of the company is Zhao Guofeng [1]

Core Viewpoint - Jiu Ri New Materials (688199) reported a narrowed loss in its 2025 mid-year financial results, with total revenue declining and net profit improving year-on-year [1] Financial Performance - Total revenue for the first half of 2025 was 713 million yuan, a decrease of 7.11% compared to the previous year [1] - The net profit attributable to shareholders was -9.0573 million yuan, showing a year-on-year improvement of 29.69% [1] - In Q2 2025, total revenue was 357 million yuan, down 13.14% year-on-year, while net profit attributable to shareholders was 1.467 million yuan, up 117.28% year-on-year [1] - Gross margin was 13.5%, a decrease of 1.96% year-on-year, while net margin was -1.75%, an increase of 4.75% year-on-year [1] - Total operating expenses (selling, administrative, and financial) amounted to 55.6017 million yuan, accounting for 7.79% of revenue, an increase of 7.02% year-on-year [1] - Earnings per share were -0.06 yuan, an increase of 25.0% year-on-year, while operating cash flow per share was 0.25 yuan, up 726.08% year-on-year [1] Debt and Cash Flow - The company has a healthy cash position, with cash assets amounting to 686 million yuan, a 15.70% increase year-on-year [1][2] - The debt situation shows an interest-bearing debt of 1.076 billion yuan, a decrease of 6.04% year-on-year, with an interest-bearing asset-liability ratio of 24.91% [3] Market Position and Analyst Expectations - Analysts expect the company's performance in 2025 to reach 45 million yuan, with an average earnings per share forecast of 0.28 yuan [4] - The company has seen new investments from several funds, indicating growing interest in its stock [5]

一、强化主业优势，提升市场占有率 天津久日新材料股份有限公司 关于公司 2025 年度"提质增效重回报"行动方案 的半年度评估报告 天津久日新材料股份有限公司（以下简称公司）始终践行"以投资者为本" 的上市公司发展理念，维护广大投资者特别是中小投资者的利益，基于对公司未 来持续稳定发展的信心和对公司长期价值的认可，公司于 2025 年 4 月 19 日发布 了《天津久日新材料股份有限公司关于公司 2024 年度"提质增效重回报"行动 方案年度评估报告暨 2025 年度"提质增效重回报"行动方案》，对公司在 2024 年度开展的"提质增效重回报"行动进行了全面评估，并在此基础上，为进一步 深化提质增效举措，持续提升公司核心竞争力，公司制定了《2025 年度"提质 增效重回报"行动方案》（以下简称《行动方案》）。 2025 年上半年，公司切实履行并持续评估《行动方案》的具体举措，现将 《行动方案》半年度实施情况报告如下： 为实现公司光引发剂产品 184 全产业链的贯通，进一步增强市场竞争力，并 延伸公司控股孙公司湖南弘润化工科技有限公司（以下简称弘润化工）的苯甲酸 产品以完善产业布局，公司于 2025 年上半年对 ...

证券代码：688199 证券简称：久日新材 公告编号：2025-044 天津久日新材料股份有限公司 截 至 2025 年 6 月 30 日 ， 公 司 对 募 集 资 金 投 资 项 目 累 计 投 入 1,128,108,981.83 元，其中：于 2019 年 10 月 31 日起至 2024 年 12 月 31 日止 期 间 使 用 募 集 资 金 1,068,791,172.99 元 ； 2025 年 半 年 度 使 用 募 集 资 金 59,317,808.84 元。募集资金余额为 581,183,971.45 元。 二、募集资金的管理情况 根据有关法律法规及《上市公司募集资金监管规则》《上海证券交易所科创 板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规 范运作》的规定，遵循规范、安全、高效、透明的原则，公司制定了《天津久日 新材料股份有限公司募集资金管理制度》（以下简称《管理制度》），对募集资 1 金的存储、审批、使用、管理与监督做出了明确的规定，以在制度上保证募集资 金的规范使用。 2019 年 10 月 30 日，公司、久日新材料（东营）有限公司（以下简称东营 久日 ...

一、本次计提减值准备情况概述 根据《企业会计准则》及天津久日新材料股份有限公司（以下简称公司）会 计政策、会计估计的相关规定，为真实、准确地反映公司截至 2025 年 6 月 30 日的财务状况及经营成果，本着谨慎性原则，公司对截至 2025 年 6 月 30 日公司 及子公司的应收账款、其他应收款、长期应收款、存货等资产进行了减值测试， 2025 年半年度确认的各项资产减值损失合计为 650.14 万元，具体情况如下： 单位：万元 | 资产名称 | 2025 年半年度计提减值损失金额 | | --- | --- | | 坏账损失 | -63.30 | | 存货跌价损失 | -586.84 | | 合计 | -650.14 | 二、本次计提资产减值准备的具体说明 证券代码：688199 证券简称：久日新材 公告编号：2025-046 天津久日新材料股份有限公司 关于 2025 年半年度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 四、其他说明 本次计提的各项资产减值准备的相关财务数据未经会计师事务 ...

天津久日新材料股份有限公司 第五届监事会第二十四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 证券代码：688199 证券简称：久日新材 公告编号：2025-043 一、监事会会议召开情况 天津久日新材料股份有限公司（以下简称公司）第五届监事会第二十四次会 议（以下简称本次会议）于 2025 年 8 月 21 日在公司会议室以现场方式召开，本 次会议通知已于 2025 年 8 月 10 日以专人送出等方式送达全体监事。本次会议应 出席监事 3 人，实际出席监事 3 人，由监事会主席罗想先生召集并主持。本次会 议的召开符合《中华人民共和国公司法》及《天津久日新材料股份有限公司章程》 （以下简称《公司章程》）等有关法律、法规、规范性文件的规定，程序合法。 二、监事会会议审议情况 经与会监事认真讨论，审议并通过如下事项： （一）审议通过《关于公司 2025 年半年度报告及摘要的议案》 经与会监事审议，公司监事会认为：公司 2025 年半年度报告及摘要的编制 和审议程序符合法律、法规、《公司章程》和公司内部管理制 ...

证券代码：688199 证券简称：久日新材 公告编号：2025-045 关于参与设立的投资基金减资、延长存续期 暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 交易简要内容：截至 2025 年 4 月 6 日，天津久日新材料股份有限公司（以 下简称公司）参与设立的天津市瑞武股权投资基金合伙企业（有限合伙）（以下简 称合伙企业、瑞武基金）共收回投资款 2,300.00 万元，并已向全体合伙人分配 2,260.00 万元，按照《天津市瑞武股权投资基金合伙企业（有限合伙）合伙协议》 （以下简称《合伙协议》）的约定，瑞武基金拟对已分配的 2,260.00 万元进行减资 处理，即瑞武基金的认缴出资额由 10,000.00 万元扣减 2,260.00 万元后变更为 7,740.00 万元，各合伙人按照出资比例等比例减资。本次减资完成后，公司对瑞 武基金的认缴出资额将由3,800.00万元减少至2,941.20万元，认缴出资比例不变， 仍为 38.00%。同时，鉴于瑞武基金存续期将于 2025 年 11 ...

Meeting Overview - The fifth meeting of the Supervisory Board of Tianjin Jiuri New Materials Co., Ltd. was held on August 21, 2025, with all three supervisors present, ensuring compliance with relevant laws and regulations [1][2]. Financial Reporting - The Supervisory Board approved the 2025 semi-annual report and its summary, confirming that the report's preparation and review processes adhered to legal and internal regulations, and accurately reflected the company's financial status without any misleading information [1][2]. Fund Management - The Supervisory Board approved the special report on the management and actual use of raised funds for the first half of 2025, indicating proper management practices [2]. Investment Fund Adjustment - The Supervisory Board approved the reduction of capital and extension of the duration of an investment fund established by the company, stating that this decision would optimize the fund's capital structure and was based on a comprehensive assessment of market conditions and investment projects [2][3].

Core Viewpoint - The company has implemented a "Quality Improvement and Efficiency Enhancement" action plan for 2025, focusing on strengthening its core business, optimizing production capacity, and enhancing market competitiveness while maintaining investor interests [1][8]. Group 1: Business Performance and Strategy - In the first half of 2025, the company achieved a net profit attributable to shareholders of -9.0573 million yuan, a reduction in loss by 3.8239 million yuan compared to the same period last year, indicating a 29.69% improvement in loss narrowing [1]. - The company has successfully implemented a price increase strategy for its photoinitiator products, leading to a slight profit in Q2 2025 and an overall positive operational trend [1]. - The company has completed the development of 29 semiconductor g-line and i-line photoresist products, with 13 successfully introduced to the market, indicating strong market acceptance [3]. Group 2: Production and Capacity Optimization - The company has optimized the use of 50 million yuan of previously unutilized fundraising to support the H4 ketone project at its subsidiary, enhancing production efficiency and self-sufficiency in key intermediates [2]. - The overall capacity utilization rate of the company's subsidiary in Inner Mongolia has significantly improved, with several products reaching or nearing design capacity [2]. - The company is advancing digital capabilities, including the launch of an AI-driven customer service system to enhance response speed and resource allocation [3]. Group 3: Innovation and Product Development - The company holds 192 patents, including 128 invention patents, and has developed a range of macromolecular products, with significant sales in UV LED photoinitiators and cationic photoinitiators [5]. - The company has established a project database to track customer needs and provide comprehensive solutions, enhancing its market promotion efforts [5]. - An internal innovation competition has been held to stimulate employee creativity, with rewards provided to winning teams to encourage ongoing innovation [6]. Group 4: Governance and Compliance - The company is enhancing its internal governance structure and compliance awareness among key personnel through targeted training sessions [7]. - A special task force has been established to revise internal control systems, ensuring compliance and effective governance [7]. - The company has been recognized as a "Green Supply Chain Management Enterprise" for its commitment to sustainable development and carbon reduction initiatives [7]. Group 5: Investor Relations and Communication - The company emphasizes investor relations, conducting multiple communication initiatives, including a performance briefing and interactive Q&A sessions, achieving a 100% response rate to investor inquiries [8]. - The company has utilized new media platforms to enhance communication with investors, publishing 27 articles to keep them informed [8]. - Continuous evaluation of the action plan will be conducted to ensure alignment with investor interests and market expectations [8].